Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil

EGFR, ALK and MET exon 14 skip are prevalent lung cancer drivers in Brazil, but detection by NGS is not feasible in 1/3 of the cases.

Saved in:

Bibliographic Details
Published in:	JCO global oncology Vol. 10; no. 10; p. e2400354
Main Authors:	Dienstmann, Rodrigo, da Silva, Leonard M., Orpinelli Ramos do Rego, Fernanda, Muniz Rodrigues, Amanda, Koyama, Fernanda Christtanini, Galindo, Layla Testa, de Bustamante Fernandes, Carolina, de Souza, Bruno Batista, Paes, Rafael Duarte, Montella, Tatiane, de Marchi, Pedro, Jeha Araújo, Breno, Ferrari, Bruno Lemos, Mathias, Clarissa, Pereira, Emilio, Zalis, Mariano Gustavo, Leslin, Chesley, Ferreira, Carlos Gil
Format:	Journal Article
Language:	English
Published:	American Society of Clinical Oncology 01-11-2024
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	EGFR, ALK and MET exon 14 skip are prevalent lung cancer drivers in Brazil, but detection by NGS is not feasible in 1/3 of the cases.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2687-8941 2687-8941
DOI:	10.1200/GO-24-00354